1,2-dimyristoyl-rac-glycero-3-methoxypolyethylene glycol-2000 (PEG2000-DMG).Doses withdrawn in advance of administration should be clearly labelled.įor infants aged <12 months: Intramuscular injection into vastus lateralis muscle of the anterolateral thighĮach 0.25 mL dose contains 25 μg mRNA encoding the SARS-CoV-2 spike glycoprotein To minimise the risk of administration errors, providers should preferably prepare and store doses of these vaccines separately. Note that Moderna bivalent original/Omicron BA.1 ≥18 years formulation (blue cap/green label) also has a blue cap. Moderna 6 months to 5 years formulation (blue cap/purple stripe) Brand name Spikevax, generic name elasomeran or mRNA-1273Ģ.5 mL multidose vial without preservativeīlue cap/purple stripe. Doses withdrawn in advance of administration should be clearly labelled.Įach 0.3 mL dose contains 15 µg of tozinameran and 15 µg of famtozinameran Note that Pfizer bivalent original/Omicron BA.1 ≥ 18 years formulation also has a grey cap. Pfizer bivalent original/Omicron BA.4/5 ≥12 years formulation (grey cap) Brand name Comirnaty, generic name tozinameran/famtozinameran ((4-hydroxybutyl)azanediyl)bis(hexane-6,1-diyl)bis (2-hexyldecanoate) (ALC-0315).Intramuscular injection into deltoid muscleĮach 0.3 mL dose contains 15 µg of tozinameran and 15 µg of riltozinameran Doses withdrawn in advance of administration should be clearly labelled. Note that Pfizer bivalent original/Omicron BA.4/5 ≥ 12 years formulation also has a grey cap. Multidose vial containing 6 doses in 2.25 mL. Pfizer bivalent original/Omicron BA.1 ≥18 years formulation (grey cap) Brand name Comirnaty, generic name tozinameran or BNT162b2 (OMI) BA.1 2-N,N-ditetradecylacetamide (ALC-0159).((4-hydroxybutyl)azanediyl)bis(hexane-6,1-diyl)bis(2-hexyldecanoate) (ALC-0315).Requires dilution with 2.2 mL of sterile 0.9% NaCl without preservative into each multidose vialįor infants aged 6 to 12 months: Intramuscular injection into vastus lateralis muscle of the anterolateral thighįor children aged ≥12 months: Intramuscular injection into deltoid muscle (or into the vastus lateralis muscle of the anterolateral thigh)Įach 0.2 mL dose contains 3 µg mRNA encoding the SARS-CoV-2 spike glycoprotein Multidose vial containing 10 doses in 0.4 mL.
0 Comments
Leave a Reply. |
Details
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |